It can regulate the expression of key enzymes involved in hepatic gluconeogenesis (such as PEPCK), activate thermogenesis in brown adipose tissue, and improve obesity-related metabolic syndromes (Xu et al. 2015). This evidence concerns the gene PCK2 and obesity due to melanocortin 4 receptor deficiency.